Delivery of mesenchymal stem cells in biomimetic engineered scaffolds promotes healing of diabetic ulcers.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 26986810)

Published in Regen Med on March 17, 2016

Authors

Roland Assi1, Trenton R Foster1, Hao He1,2, Katerina Stamati3, Hualong Bai1, Yuegao Huang4, Fahmeed Hyder4, Douglas Rothman4, Chang Shu2, Shervanthi Homer-Vanniasinkam3, Umber Cheema3, Alan Dardik1,5

Author Affiliations

1: Vascular Biology & Therapeutics Program & the Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
2: Department of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
3: UCL Institute of Orthopaedics & Musculoskeletal Sciences, UCL Division of Surgery & Interventional Sciences, University College London, London, UK.
4: Departments of Diagnostic Radiology & Biomedical Engineering, Yale University, New Haven, CT, USA.
5: Department of Surgery, VA Connecticut Healthcare Systems, West Haven, CT, USA.

Articles cited by this

Economic costs of diabetes in the U.S. in 2012. Diabetes Care (2013) 11.74

Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation. Science (2013) 6.43

Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells (2007) 5.83

Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol (2008) 3.67

Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen (2004) 3.60

Treatment for diabetic foot ulcers. Lancet (2005) 1.91

Clinical applications of mesenchymal stem cells. J Hematol Oncol (2012) 1.86

Harnessing nanotopography and integrin-matrix interactions to influence stem cell fate. Nat Mater (2014) 1.83

Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PLoS One (2012) 1.65

Diabetes irreversibly depletes bone marrow-derived mesenchymal progenitor cell subpopulations. Diabetes (2014) 1.61

Extracellular matrix scaffold for cardiac repair. Circulation (2005) 1.55

Extracellular matrix: a dynamic microenvironment for stem cell niche. Biochim Biophys Acta (2014) 1.45

Collagen matrix physical properties modulate endothelial colony forming cell-derived vessels in vivo. Microvasc Res (2010) 1.45

Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Mol Ther (2010) 1.31

Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther (2010) 1.28

Diabetes impairs the angiogenic potential of adipose-derived stem cells by selectively depleting cellular subpopulations. Stem Cell Res Ther (2014) 1.24

Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med (2011) 1.19

The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk. J Diabetes Complications (2014) 1.08

Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. Tissue Eng Part A (2009) 1.03

Spatially defined oxygen gradients and vascular endothelial growth factor expression in an engineered 3D cell model. Cell Mol Life Sci (2008) 0.99

Regulation of proliferation and chondrogenic differentiation of human mesenchymal stem cells by laminin-5 (laminin-332). Stem Cells (2006) 0.98

Stem cells for skin tissue engineering and wound healing. Crit Rev Biomed Eng (2009) 0.96

Oxygen diffusion through collagen scaffolds at defined densities: implications for cell survival in tissue models. J Tissue Eng Regen Med (2011) 0.91

Diabetic foot ulcers--a comprehensive review. Surgeon (2007) 0.90

Adipose-derived cell construct stabilizes heart function and increases microvascular perfusion in an established infarct. Stem Cells Transl Med (2013) 0.87

Mesenchymal stem cells and their microenvironment. Front Biosci (Landmark Ed) (2011) 0.87

Redox regulation of stem cell mobilization. Can J Physiol Pharmacol (2009) 0.86

The Role of Mesenchymal Stem Cells in the Regenerative Wound Healing Phenotype. Adv Wound Care (New Rochelle) (2012) 0.86

Evolution of oxygen utilization in multicellular organisms and implications for cell signalling in tissue engineering. J Tissue Eng (2011) 0.84

Scarring, stem cells, scaffolds and skin repair. J Tissue Eng Regen Med (2013) 0.84

Streptozotocin is equally diabetogenic whether administered to fed or fasted mice. Lab Anim (2013) 0.83

The role of stem cells in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract (2011) 0.83

Reduction of diabetic foot ulcer healing times through use of advanced treatment modalities. Int J Low Extrem Wounds (2014) 0.83

Switching off angiogenic signalling: creating channelled constructs for adequate oxygen delivery in tissue engineered constructs. Eur Cell Mater (2010) 0.82

Laminin promotes vascular network formation in 3D in vitro collagen scaffolds by regulating VEGF uptake. Exp Cell Res (2014) 0.81

Treating diabetic ulcers. Expert Opin Pharmacother (2011) 0.80

Biomaterial Scaffolds for Controlled, Localized Gene Delivery of Regenerative Factors. Adv Wound Care (New Rochelle) (2013) 0.79

Progress in stem cell therapy for the diabetic foot. Diabetes Res Clin Pract (2012) 0.79

The use of AlloDerm in the reconstruction of full-thickness eyelid defects. Orbit (2008) 0.79

Ultra-rapid engineered collagen constructs tested in an in vivo nursery site. J Tissue Eng Regen Med (2007) 0.78

Murine models of human wound healing. Methods Mol Biol (2013) 0.78